查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1408261

藥筒：市場佔有率分析、產業趨勢與統計、2024-2029 年成長預測

Pharmaceutical Cartridges - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2024 - 2029
出版日期: | 出版商: Mordor Intelligence | 英文 90 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計在預測期內，藥筒市場將以 7.5% 的複合年成長率大幅成長。

藥筒-市場-IMG1

由於藥筒生產和分銷的中斷，COVID-19 大流行在最初階段擾亂了藥筒市場。然而，疫情也創造了對藥筒的巨大需求，並導致對各種藥品、疫苗和其他基本藥物的需求激增。例如，截至 2022 年 4 月，全球總合給藥了114 億劑 COVID-19 疫苗。美國、中國、印度、德國和英國等具備疫苗生產能力的國家每100人給藥超過100劑疫苗。此外，2021年將供應約160億劑（相當於1,410億美元）疫苗，約2019年供應量的3.5倍。由此可見，疫苗的龐大需求對藥筒市場產生了正面影響。

推動藥筒市場成長的關鍵因素是製藥業研發（R＆D）支出的增加、藥物輸送設備的技術發展以及慢性病盛行率的增加。例如，據 SHL Medical 稱，到 2022 年，將開發一種稱為針隔離技術 (NIT) 的創新方法來解決藥筒注射器的問題。使用NIT，針頭隱藏在注射器內，因此無需手動插入針頭。使用 NIT，使用者只需在注射前取下蓋子並插入針頭，即可打開流體途徑並自動灌註注射器。此類產品的進步將有助於藥筒市場的成長。

然而，新藥的開發創造了對藥筒產品的需求。例如，根據國際藥品製造商聯合會的報告，2022年將有64種新活性物質（NAS）在全球上市，目前有超過6,147種產品正處於從第一階段到核准備案的積極開發中。目前，所有治療領域正在開發的藥物超過 9,000 種，疫苗有 260 種。此類新藥的開發可能會在預測期內創造對藥筒的需求。

然而，與材料相關的挑戰，例如運輸過程中的損壞和破損，可能會阻礙藥筒市場的成長。

藥用墨盒市場趨勢

預計玻璃材質在預測期內將佔據主要市場佔有率

預計在預測期內，玻璃材料領域的藥筒市場將顯著成長。這主要是由於對其卓越品質和比塑膠更強的耐化學性的需求增加。這些墨盒具有最低的膨脹係數，並且具有很強的抗熱衝擊和抗應力能力。它能抵抗多種物質的損害，並且由於熔點高而洗脫率低。玻璃藥筒與各種常用的給藥筆和自動注射器相容，例如牙醫的局部麻醉和糖尿病患者的胰島素。

此外，玻璃藥筒不可吸收且不可洗脫，這對於保持生物製藥和敏感藥品的純度和效力以及提供長期的產品保護非常重要。醫療專業人員可以透過玻璃材質輕鬆檢查給藥、檢查內容物以及檢查是否有雜質。玻璃還具有化學惰性，不會與大多數藥物物質發生反應。這使其成為保存和儲存各種藥品的安全可靠的材料，且不會影響功效和安全性。

此外，COVID-19 大流行增加了對注射藥物的需求，增加了生物製藥公司縮短上市時間的壓力。因此，2021 年 6 月，SGD Pharma 宣布 20ml EasyLyo 模壓玻璃 1 型管瓶現已以即用型形式提供給消費者。 SGD Pharma 是第一家提供工業規模注射用 RTU管瓶的玻璃模具製造商。此外，我們與 Stevanato Group 合作，首次推出了 EZ-fill Nest &Tub 的 20ml EasyLyo 玻璃模製 I 型管瓶。

藥筒-市場-IMG2

預計北美將在預測期內主導市場

預計在預測期內，北美將主導藥筒市場。市場的關鍵因素是高度發展的醫療基礎設施和確保對製藥業進行嚴格監管的權威。

對藥品和精確給藥系統的需求不斷成長是該地區市場成長的主要驅動力。慢性病的流行、人口老化以及製藥業新技術的採用和進步推動了對藥品的高需求。例如，美國癌症協會報告稱，癌症是美國第二大死因。此外，到 2023 年，每天可能會診斷出 195 萬新癌症病例，相當於 5,370 例。因此，癌症很可能會增加對藥品的需求，並進一步推動藥筒市場的成長。

此外，主要企業增加加拿大和美國製藥業的研發支出也促進了該地區的市場成長。例如，在美國，拜耳公司計劃在2023年3月投資10億美元用於藥品研發。此外，2022年約有25家製藥公司在研發方面投入大量資金。頂級投資者包括羅氏公司、默克公司、輝瑞公司、諾華公司和阿斯特捷利康公司。其中，羅氏2022年投資1,470萬美元，較2021年大幅成長27.1%。輝瑞是全球製藥業的領導者，2022 年研發支出為 114 億美元。因此，研發支出的增加正在推動藥品成長，這也將增強該地區的藥筒需求。

因此，由於上述因素，該地區的藥筒市場預計在預測期內將會成長。

醫藥墨盒產業概況

藥筒市場的競爭是溫和的。市場上的主要企業包括 Schott AG、Nipro Corporation、Stevanato Group、West Pharmaceutical Services, Inc、Gerresheimer AG 和 Merck KGaA。公司正在採取各種策略來加強其市場地位，包括產品發布、將產品和服務擴展到新的地區、併購以及建立新的合作夥伴關係和聯盟。

其他福利：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

目錄

第1章簡介

  • 研究假設和市場定義
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場促進因素
    • 對易於使用和方便的藥品包裝解決方案的需求不斷成長
    • 醫藥業研發費用增加
  • 市場抑制因素
    • 藥筒的製造複雜性和嚴格的法規遵從性
  • 波特五力分析
    • 新進入者的威脅
    • 買家/消費者的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間敵對關係的強度

第5章市場區隔（以金額為準的市場規模 - 百萬美元）

  • 按材質
    • 玻璃
      • 類型1
      • 2型
      • 類型3
      • 類型4
    • 塑膠
      • 聚對苯二甲酸Terephthalate(PET)
      • 高密度聚苯乙烯（HDPE）
      • 其他塑膠
    • 橡皮
  • 按容量
    • 3ml以下
    • 3～5ml
    • 5～10ml
    • 10ml以上
  • 按治療區域
    • 眼科
    • 呼吸系統
    • 神經
    • 腫瘤學
    • 免疫學
    • 循環系統
    • 糖尿病學
    • 牙科
    • 其他治療領域
  • 按最終用戶
    • 製藥公司
    • 生技公司
    • 其他最終用戶
  • 按地區
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 義大利
      • 西班牙
      • 歐洲其他地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳洲
      • 韓國
      • 其他亞太地區
    • 中東/非洲
      • 海灣合作理事會國家
      • 南非
      • 其他中東/非洲
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地區

第6章 競爭形勢

  • 公司簡介
    • Merck KGaA
    • Nipro Corporation
    • Schott AG
    • Stevanato Group
    • West Pharmaceutical Services, Inc.
    • Gerresheimer AG
    • Datwyler Holding Inc.
    • AptarGroup, Inc.
    • Transcoject GmbH
    • Shandong Province Medicinal Glass Co., Ltd.
    • Kalbag Filters Pvt.
    • Kel India Filters

第7章 市場機會及未來趨勢

簡介目錄
Product Code: 50000907
Pharmaceutical Cartridges - Market - IMG1

The Pharmaceutical Cartridges Market is expected to grow at a significant CAGR of 7.5% during the forecast period.

The COVID-19 pandemic has disrupted the pharmaceutical cartridges market in the initial phase due to the disruptions in the production and distribution of pharmaceutical cartridges. However, the pandemic has also led to a surge in demand for a wide range of drugs, vaccines, and other essential pharmaceuticals which created a huge demand for pharmaceutical cartridges. For instance, a total of 11.4 billion doses of COVID-19 vaccines have been administered globally as of April 2022. Countries with vaccine manufacturing capabilities such as the United States, China, India, Germany, and the United Kingdom have administered more than 100 vaccine doses per 100 people. Also, around 16 billion vaccine doses worth USD 141 billion were supplied in 2021 which is nearly 3.5 times of 2019. Thus, the huge demand for vaccines positively impacted the pharmaceutical cartridges market.

The key factors driving the growth of the pharmaceutical cartridges market are the increase in research & development (R&D) spending in the pharmaceutical industry, technological advancements in drug delivery devices, and the growing prevalence of chronic diseases. For instance, in 2022, according to SHL Medical an innovative method known as Needle Isolation Technology (NIT) is developed to address the problems with cartridge-based injection devices. Based on a pre-installed needle hidden inside the device, the technology eliminates the need for users to manually attach the needle. With NIT, users merely remove the cap to insert the needle prior to injection, allowing the fluid route to be opened and the injector to automatically prime. Such advancements in products will contribute to the growth of the pharmaceutical cartridge market.

However, the development of new drugs creates demand for pharmaceutical cartridges products. For instance, according to a report by the International Federation of Pharmaceutical Manufacturers and Associations, globally, 64 novel active substances (NAS) have been launched in 2022, while more than 6,147 products are currently in active development from Phase 1 to regulatory submission. There are currently more than 9,000 drugs in development across all therapeutic areas, along with 260 vaccines. Such developments of novel drugs are likely to create demand for pharmaceutical cartridges over the forecast period.

However, the challenges associated with material such as damage or breakage during transportation may hinder the growth of the pharmaceutical cartridges market.

Pharmaceutical Cartridges Market Trends

Glass Material is Expected to have Significant Market Share during the Forecast Period

The glass material segment is expected to witness significant growth in the pharmaceutical cartridges market over the forecast period. This is largely due to increased demand for their superior quality and stronger chemical resistance than plastics. These cartridges have the lowest coefficient of expansion and a high level of thermal shock and stress tolerance. It is resistant to damage from many substances and has less leaching due to characteristics such as a high melting point. Glass cartridges are compatible with a wide range of pens and auto-injectors that are often utilized for administering drugs, including local dental anesthesia and insulin for people with diabetes.

Also, there are several advantages of glass material over plastic that includes the non-absorbent and non-leaching nature of glass cartridges which is crucial for preserving the purity and effectiveness of biological & sensitive drugs and providing product protection over a period. It is easy for healthcare professionals to check the dosage, inspect the content and check for any impurities through glass material. Also, glass is chemically inert, and it does not react with most pharmaceutical substances. This makes it secure and dependable material for preserving and storing a wide range of drugs without compromising efficacy and safety.

Furthermore, the COVID-19 pandemic has increased the demand for parenteral drugs, which has increased the pressure on biopharmaceutical companies to reduce their time to market. Thus, in June 2021, SGD Pharma announced that 20ml EasyLyo molded glass Type 1 vials were available to consumers in a ready-to-use manner. SGD Pharma was the first manufacturer of molded glass to deliver RTU vials for injectable drugs on an industrial scale. Also, due to the company's collaboration with the Stevanato Group, it has also been the first to market 20ml EasyLyo molded glass Type I vials in EZ-fill Nest & Tub.

Pharmaceutical Cartridges - Market - IMG2

North America is Expected to Dominate the Market Over the Forecast Period

North America is expected to dominate the pharmaceutical cartridges market over the forecast period. The key factors contributing to the market are highly developed healthcare infrastructure, and well-established authorities ensuring stringent regulatory monitoring of the pharmaceutical industry.

The increasing demand for drugs & precise drug delivery systems is a major factor contributing to the market growth in the region. The high demand for drugs has been influenced by the prevalence of chronic diseases, the rising aging population, and the adoption of new technologies and advancements in the pharmaceutical industry. For instance, according to the American Cancer Society report, cancer is the second most prevalent cause of mortality in the United States. Also, 1.95 million new cases of cancer, which is equal to 5,370 cases every day are likely to be diagnosed in the country in 2023. Hence, cancer is increasing the demand for pharmaceutical drugs which is further likely to drive the growth of the pharmaceutical cartridges market.

Furthermore, the rising R&D expenditure in the pharmaceutical industry in Canada and the United States by the top key players are also driving market growth in the region. For instance, in March 2023, in the United States, Bayer AG planned to invest USD 1.0 billion in the research & development of drugs. Also, there were around 25 pharmaceutical companies that invested heavily in R&D in 2022. The top investors include Roche, Merck & Co., Pfizer, Novartis, and AstraZeneca. Among these players, Roche invested USD 14.7 million in 2022, a significant increase of 27.1% from 2021. Pfizer, a global leader in pharmaceuticals, spent USD 11.4 billion on R&D in 2022. Thus, the increasing R&D expenses are driving the growth of pharmaceutical drugs which would also strengthen the demand for cartridges in the region.

Therefore, due to the factors mentioned above, the pharmaceutical cartridges market is expected to grow in the region over the forecast period.

Pharmaceutical Cartridges Industry Overview

The pharmaceutical cartridges market is moderately competitive. Some of the key players operating in the market include Schott AG, Nipro Corporation, Stevanato Group, West Pharmaceutical Services, Inc, Gerresheimer AG, and Merck KGaA. Companies are adopting various strategies such as product launches, expansion of the products and services into new regions, mergers & acquisitions, and entering new partnerships and collaborations to strengthen their position in the market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Easy to Use and Convenient Pharmaceutical Packaging Solutions
    • 4.2.2 Increase in R&D Spending in the Pharmaceutical Industry
  • 4.3 Market Restraints
    • 4.3.1 Manufacturing Complexity and Stringent Regulatory Compliance Related to Pharmaceutical Cartridges
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Material
    • 5.1.1 Glass
      • 5.1.1.1 Type 1
      • 5.1.1.2 Type 2
      • 5.1.1.3 Type 3
      • 5.1.1.4 Type 4
    • 5.1.2 Plastic
      • 5.1.2.1 Polyethylene Terephthalate (PET)
      • 5.1.2.2 High-Density Polyethylene (HDPE)
      • 5.1.2.3 Other Plastic Material
    • 5.1.3 Rubber
  • 5.2 By Capacity
    • 5.2.1 Less than 3ml
    • 5.2.2 3ml-5ml
    • 5.2.3 5ml-10ml
    • 5.2.4 More than 10 ml
  • 5.3 By Therapeutic Area
    • 5.3.1 Ophthalmology
    • 5.3.2 Respiratory
    • 5.3.3 Neurology
    • 5.3.4 Oncology
    • 5.3.5 Immunology
    • 5.3.6 Cardiology
    • 5.3.7 Diabetes
    • 5.3.8 Dental
    • 5.3.9 Other Therapeutic Area
  • 5.4 By End User
    • 5.4.1 Pharmaceutical Companies
    • 5.4.2 Biotechnology Companies
    • 5.4.3 Other End Users
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Merck KGaA
    • 6.1.2 Nipro Corporation
    • 6.1.3 Schott AG
    • 6.1.4 Stevanato Group
    • 6.1.5 West Pharmaceutical Services, Inc.
    • 6.1.6 Gerresheimer AG
    • 6.1.7 Datwyler Holding Inc.
    • 6.1.8 AptarGroup, Inc.
    • 6.1.9 Transcoject GmbH
    • 6.1.10 Shandong Province Medicinal Glass Co., Ltd.
    • 6.1.11 Kalbag Filters Pvt.
    • 6.1.12 Kel India Filters

7 MARKET OPPORTUNITIES AND FUTURE TRENDS